Spanish ingredients supplier Monteloeder says the market for skin lightening products will continue to grow rapidly—but that many consumers in the category will turn away from topically applied products in favour of dietary supplements that offer “lighter skin from within.”
Monteloeder markets Melagenol, a natural oral nutricosmetic formulation that offers excellent skin lightening and whitening properties. Produced from plant extracts, it is proven safe and effective as both a beauty aid and in the treatment of skin pigmentation disorders.
Melagenol is designed as an alternative to skin lightening creams and lotions, which often cause localised discoloured skin patches. When taken orally as a dietary supplement, Melagenol protects the whole body from the appearance of unwanted marks—avoiding discolouration.
Melagenol works by influencing the different pathways involved in the synthesis of melanin—the chemical that causes the skin to darken. Thanks to its relatively low required dosage (300 to 500 mg daily), it can be easily applied in a range of orally consumed dietary supplement products, including capsules, effervescent tablets, sachets and candy.
Monteloeder has produced a new white paper detailing the benefits of Melagenol. It is available to download free of charge here.
Fernando Cartagena, director of Monteloeder, said: “Sales of skin lightening products will be worth about US$20 billion by 2018, but the topical products on the market today often cause as many problems as they solve. Melagenol has none of these issues. It simply offers highly effective skin-lightening without side effects, which means it is ideal for both general skin whitening and the treatment of unwanted dark patches on the skin. With Melagenol, it is now possible for beauty companies to create products that offer consumers lighter skin from within.”
There is strong scientific evidence to support the efficacy of Melagenol. In a recent study performed at the University Miguel Hernandez in Elche, Spain, it was shown to inhibit melanin production in melanocytes, the cells that produce melanin, in a dose-response manner—thus preventing the appearance of unattractive dark spots on the skin.